Similar to tariffs in which Trump felt that the United States was not treated fairly when it came to be taxed on certain ...

In the final part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

The financial decision is due to customer demand stemming from the reshoring of drug supply services.

In the third part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

In the second part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are ...

Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in ...

A multi-national study reveals over half of older adults in several European countries are prescribed five or more ...

Doug Long, VP, industry relations, IQVIA, discusses how soaring demand for GLP-1 therapies is driving reimbursement challenges, shifting distribution models, and expanding the drugs’ potential into ...

In the first part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

How the 2028 Medicare drug price negotiations will reshape market access, provider reimbursement, and patient care ...

The move bolsters the CDMO’s commitment to cell and gene therapy by incorporating advanced manufacturing and fill-finish ...